Connect with us

Business

Sanofi in Talks for Partial Sale of Opella to US Private Equity Firm CD&R

Published

on

PARIS, FRANCE — French pharmaceutical giant Sanofi has entered exclusive negotiations with U.S. private equity firm Clayton Dubilier & Rice (CD&R) regarding the partial sale of its subsidiary, Opella. The talks mark a significant step in Sanofi’s plan to sell a portion of Opella while maintaining a stake in the business.

The announcement follows the French government’s decision to acquire a 2% stake in Opella through the state-owned investment firm Bpifrance. The investment, valued between €100 million and €150 million, will also give the government a seat on Opella’s board.

As part of the deal, CD&R and Sanofi have made several key commitments to safeguard jobs and operations in France. Opella’s workforce in the country will be protected, with a €100,000 penalty for each job lost. The companies also agreed to maintain Opella’s headquarters and research and development (R&D) activities in France, with plans to invest €70 million in the country over the next five years.

The decision to sell a stake in Opella to a U.S. firm has sparked significant backlash in France. Concerns were raised earlier this month about potential job losses and the risk of medicine shortages. These fears have been heightened since the COVID-19 pandemic, which exposed vulnerabilities in pharmaceutical supply chains and led to public calls for increased onshoring of drug production.

Opella, known for producing France’s top-selling painkiller, Doliprane, holds a strong position in the domestic market. The potential sale has raised concerns about the future of French jobs and the stability of drug supplies. However, Sanofi has emphasized that it will retain approximately half of the business, allowing it to remain a key player in Opella’s future.

In its statement, Sanofi noted that the offer from CD&R is “binding and fully financed,” adding that the private equity firm has a long history of investment in Europe, including building French national champions and supporting local employment for over two decades.

Sanofi clarified that by remaining a major shareholder in Opella, it would continue to benefit from the company’s future growth. The partial sale values Opella at around €16 billion.

Pending regulatory approval from the French government, the transaction is expected to be finalized by the second quarter of 2025.

The deal underscores ongoing discussions in France about the importance of safeguarding national interests in critical industries like pharmaceuticals, particularly in light of recent global supply chain disruptions.

Business

Top Jobs in the UK for 2025: Teachers, Solicitors, and AI Engineers Lead the Way

Published

on

By

School teachers, solicitors, and AI engineers are among the most in-demand professions in the UK for 2025, according to a new report by global hiring platform Indeed. The analysis, based on job posting trends from 2023 to 2024, highlights high-growth roles across key sectors including education, healthcare, and technology.

School teachers top the ranking, experiencing a staggering 245% increase in job postings. This surge reflects the ongoing teacher recruitment and retention crisis, as reported in the 2024 Teacher Labour Market in England Annual Report. The report warns of a critical shortfall in teacher supply, with recruitment reaching just half of its target for 2023/24 and further declines expected for 2024/25 in secondary education.

Solicitors and Healthcare Roles See Significant Growth
Property solicitors claimed the second spot with a 111% rise in job postings, driven by growing demand in the legal sector. Employment solicitors also featured in eighth place with 93% growth.

Healthcare roles held two spots in the top 10. Doctors, specifically General Medicine Registrars, ranked seventh with a 95% increase in postings, while paediatricians secured ninth place with 91% growth. These roles highlight the persistent need for medical professionals, a trend consistently observed in Indeed’s annual job rankings.

AI/ML Engineers Make Their Debut
For the first time, Artificial Intelligence (AI) and Machine Learning (ML) engineers appeared on the list, claiming the 10th spot with an 86% increase in job postings. These specialists design and deploy machine learning models, driving innovation in areas such as automation, natural language processing, and computer vision. With an average salary of £68,560 (€81,163), AI/ML engineers are among the highest-paid professionals on the list.

Danny Stacy, Head of Talent Intelligence at Indeed, said the rankings reflect both traditional and emerging career opportunities. “This list highlights the demand for essential roles such as teachers, doctors, and solicitors while showcasing growth in emerging industries like artificial intelligence and machine learning,” he said.

High Earning Potential Across the Board
Paediatricians top the salary rankings with an average annual pay of £106,048 (€125,547), followed by commercial directors (£81,802) and AI/ML engineers. The rankings considered roles with salaries above £37,430 (€44,306), the median annual earnings for full-time employees in 2024, according to the Office for National Statistics (ONS).

Top 10 Jobs in the UK for 2025

  1. School teacher: 245% growth / £39,356
  2. Property solicitor: 111% growth / £52,929
  3. Commercial director: 108% growth / £81,802
  4. Project estimator: 102% growth / £38,854
  5. Senior user interface designer: 100% growth / £56,577
  6. Registered children’s manager: 97% growth / £43,959
  7. Doctor (General Medicine Registrar): 95% growth / £72,902
  8. Employment solicitor: 93% growth / £55,315
  9. Paediatrician: 91% growth / £106,048
  10. AI/ML engineer: 86% growth / £68,560

These findings serve as a roadmap for jobseekers navigating the evolving job market, highlighting sectors with promising career paths and strong earning potential.

Continue Reading

Business

Richemont’s Strong Quarterly Results Boost European Luxury Stocks

Published

on

By

Richemont reported impressive quarterly results on Thursday, driven by festive season sales, even as weak demand in China weighed on performance. The Swiss luxury goods giant’s robust earnings sent ripples through the European luxury sector, lifting share prices of major rivals.

Richemont’s stock surged over 16% to reach a record high of ₣161.8 (€172.45) on the Zurich Stock Exchange, marking its largest intraday gain since October 2008. The company has been a standout performer, with its share price up 21% in 2024, contrasting sharply with declines seen in other major luxury players such as LVMH and Kering last year.

Strong Fiscal Third-Quarter Performance

For the fiscal third quarter of 2025, Richemont reported sales revenue of €6.2 billion, a 10% increase year-on-year, exceeding analyst expectations. While sales in mainland China, Hong Kong, and Macau collectively fell by 18%, resulting in a 7% decline in the Asia-Pacific region, robust growth in Europe, the Americas, Japan, and the Middle East & Africa offset the weakness.

European revenue surged by 19%, bolstered by increased domestic demand and higher tourist spending from North America and the Middle East. The Group’s Jewellery Maisons—Buccellati, Cartier, Van Cleef & Arpels, and Vhernier—achieved 14% growth, driven by iconic jewellery and watch collections during the festive season.

However, Specialist Watchmakers experienced an 8% drop in revenue year-on-year, reflecting the challenges in the Asia-Pacific market. Despite this, strong growth in the Americas and the Middle East & Africa mitigated the impact, reducing the year-to-date segmental decline to 16%.

Year-to-Date Highlights

For the nine months ending December 31, 2024, Richemont recorded a 4% increase in sales at constant currency, with net cash rising to €7.9 billion from €6.8 billion in 2023. The company ended the fiscal year 2024 with record full-year sales of €20.6 billion, though quarterly sales dipped by 1% due to the Asia-Pacific slowdown.

CEO Nicolas Bos, who took over in June 2024, is credited with steering the group toward growth in alternative markets, mitigating the effects of weakened Chinese demand, a factor emphasized by former chairman Johann Rupert.

Luxury Sector Optimism

Richemont’s results buoyed the Euro Stoxx 600 Luxury Ten Index (STXLUXP), which rose nearly 7% on Thursday. Stocks of rivals LVMH, Hermès, Christian Dior, and Kering gained 9%, 4.9%, 8.6%, and 6%, respectively.

Analysts are divided on whether the downturn in Chinese luxury spending is cyclical or structural. With China accounting for a significant portion of the Asia-Pacific market, brands heavily reliant on Chinese consumers may face continued challenges in 2025. However, optimism surrounding Richemont’s results has injected renewed confidence into the sector ahead of upcoming earnings reports.

Continue Reading

Business

Germany’s Inflation Rate Hits 2.6% in December Amid Economic Struggles

Published

on

By

Germany’s year-on-year inflation rate for December was confirmed at 2.6%, according to the Federal Statistical Office, marking the third consecutive month of growth and the highest rate since January 2024. The increase was driven primarily by rising services and food prices, leaving inflation above the European Central Bank’s (ECB) 2% target.

Key Drivers of Inflation

Services prices surged at an annual rate of 4.1% in December, slightly higher than November’s 4%. Food prices also saw an uptick, climbing to 2% from 1.8% in the previous month. Meanwhile, energy prices, which had been declining, fell at a slower pace in December, recording a decrease of 1.6%, compared to a 3.7% drop in November.

Month-on-month inflation also rose, reaching 0.5% in December, up from a decline of 0.2% in November and exceeding preliminary estimates of 0.4%.

For the entire year of 2024, the average inflation rate stood at 2.2%, a significant drop from the 5.9% recorded in 2023. Core inflation, which excludes volatile items such as food and energy, fell to 3% in 2024 from 5.1% the previous year.

Economic Contraction Continues

Germany’s economy shrank by 0.2% in 2024, following a 0.3% contraction in 2023, according to recently released gross domestic product (GDP) data. The contraction reflects ongoing challenges in key sectors.

Manufacturing output declined by 3% in 2024, weighed down by sluggish performance in the car manufacturing and machinery sectors, two pillars of the German economy. The construction sector also experienced a sharp decline, shrinking 3.8% due to rising interest rates and soaring construction costs.

On the other hand, household consumption rose marginally by 0.3% for the year, supported by increased spending on transport and health.

Challenges for Growth

Both structural and cyclical pressures have impeded Germany’s economic growth. Surging competition in key export markets has created challenges for the country’s export-driven economy. Additionally, higher energy costs and geopolitical uncertainties, including trade tensions and conflicts, have exacerbated economic vulnerabilities.

Outlook and Policy Implications

The persistent inflationary pressures and economic stagnation present a complex challenge for policymakers. While inflation remains above the ECB’s target, the broader economic slowdown may necessitate continued monetary and fiscal measures to support growth.

As Germany grapples with structural weaknesses and external risks, economic recovery will likely depend on addressing these challenges while maintaining consumer confidence and industrial competitiveness.

Continue Reading

Trending